APA (7th ed.) Citation

R, A., LK, E., N, P., M, W., & J, J. (2026). A National Response to Warfarin Shortages: Evaluating Regulatory Substitution and Notified Shortages and Their Effects on Antithrombotic Dispensings, Pathology Monitoring and Adverse Event Trends in Australia. Drug safety, 49(6), 655. https://doi.org/10.1007/s40264-025-01633-7

Chicago Style (17th ed.) Citation

R, Azroun, Ellett LK, Pratt N, Ward M, and Janetzki J. "A National Response to Warfarin Shortages: Evaluating Regulatory Substitution and Notified Shortages and Their Effects on Antithrombotic Dispensings, Pathology Monitoring and Adverse Event Trends in Australia." Drug Safety 49, no. 6 (2026): 655. https://doi.org/10.1007/s40264-025-01633-7.

MLA (9th ed.) Citation

R, Azroun, et al. "A National Response to Warfarin Shortages: Evaluating Regulatory Substitution and Notified Shortages and Their Effects on Antithrombotic Dispensings, Pathology Monitoring and Adverse Event Trends in Australia." Drug Safety, vol. 49, no. 6, 2026, p. 655, https://doi.org/10.1007/s40264-025-01633-7.